Bank of America
VRTX icon

Bank of America’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank of America’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65,100
Closed -$25.5M – 8388
2025
Q3 		$25.5M Buy
65,100
+42,100
+183% +$17.6M ﹤0.01% 2379
2025
Q2 		$10.2M Buy
23,000
+1,800
+8% +$829K ﹤0.01% 3201
2025
Q1 		$10.3M Buy
21,200
+11,200
+112% +$5.22M ﹤0.01% 3108
2024
Q4 		$4.03M Sell
10,000
-10,300
-51% -$4.77M ﹤0.01% 3793
2024
Q3 		$9.44M Sell
20,300
-4,200
-17% -$2.02M ﹤0.01% 3132
2024
Q2 		$11.5M Sell
24,500
-14,900
-38% -$6.47M ﹤0.01% 2810
2024
Q1 		$16.5M Sell
39,400
-67,500
-63% -$28.5M ﹤0.01% 2477
2023
Q4 		$43.5M Buy
106,900
+61,300
+134% +$22.6M ﹤0.01% 1467
2023
Q3 		$15.9M Sell
45,600
-26,700
-37% -$9.34M ﹤0.01% 2280
2023
Q2 		$25.4M Buy
72,300
+23,900
+49% +$8.05M ﹤0.01% 1809
2023
Q1 		$15.2M Buy
48,400
+5,000
+12% +$1.5M ﹤0.01% 2398
2022
Q4 		$12.5M Buy
43,400
+9,800
+29% +$2.99M ﹤0.01% 2465
2022
Q3 		$9.73M Buy
33,600
+18,400
+121% +$5.29M ﹤0.01% 2649
2022
Q2 		$4.28M Sell
15,200
-14,000
-48% -$3.75M ﹤0.01% 3571
2022
Q1 		$7.62M Buy
29,200
+27,800
+1,986% +$6.6M ﹤0.01% 3147
2021
Q4 		$307K Sell
1,400
-23,800
-94% -$4.63M ﹤0.01% 6229
2021
Q3 		$4.57M Sell
25,200
-166,800
-87% -$32.6M ﹤0.01% 3651
2021
Q2 		$38.7M Sell
192,000
-1,100
-0.6% -$230K ﹤0.01% 1548
2021
Q1 		$41.5M Buy
193,100
+190,100
+6,337% +$41.8M ﹤0.01% 1430
2020
Q4 		$709K Hold
3,000
– – ﹤0.01% 4766
2020
Q3 		$816K Hold
3,000
– – ﹤0.01% 4364
2020
Q2 		$871K Hold
3,000
– – ﹤0.01% 4218
2020
Q1 		$714K Sell
3,000
-71,300
-96% -$16.4M ﹤0.01% 4250
2019
Q4 		$16.3M Buy
74,300
+26,600
+56% +$5.38M ﹤0.01% 2077
2019
Q3 		$8.08M Buy
47,700
+1,700
+4% +$301K ﹤0.01% 2738
2019
Q2 		$8.44M Buy
46,000
+1,900
+4% +$332K ﹤0.01% 2726
2019
Q1 		$8.11M Sell
44,100
-88,800
-67% -$16.4M ﹤0.01% 2693
2018
Q4 		$22M Sell
132,900
-94,000
-41% -$16.3M ﹤0.01% 1591
2018
Q3 		$43.7M Sell
226,900
-29,600
-12% -$5.27M 0.01% 1192
2018
Q2 		$43.6M Sell
256,500
-75,400
-23% -$11.7M 0.01% 1185
2018
Q1 		$54.1M Buy
331,900
+204,100
+160% +$33.3M 0.01% 1006
2017
Q4 		$19.2M Buy
127,800
+87,700
+219% +$13M ﹤0.01% 1834
2017
Q3 		$6.1M Buy
+40,100
New +$6.04M ﹤0.01% 2987
2017
Q2 		– Sell
-188,500
Closed -$20.6M – 7191
2017
Q1 		$20.6M Buy
188,500
+92,100
+96% +$8.11M ﹤0.01% 1717
2016
Q4 		$7.1M Buy
96,400
+90,000
+1,406% +$7.32M ﹤0.01% 2609
2016
Q3 		$558K Sell
6,400
-1,100
-15% -$104K ﹤0.01% 4553
2016
Q2 		$645K Sell
7,500
-17,500
-70% -$1.51M ﹤0.01% 4489
2016
Q1 		$1.99M Buy
25,000
+22,500
+900% +$2.04M ﹤0.01% 3574
2015
Q4 		$315K Hold
2,500
– – ﹤0.01% 5093
2015
Q3 		$260K Buy
+2,500
New +$321K ﹤0.01% 5196
2015
Q1 		– Sell
-71,400
Closed -$8.48M – 7607
2014
Q4 		$8.48M Buy
71,400
+26,600
+59% +$3M ﹤0.01% 2059
2014
Q3 		$5.03M Sell
44,800
-108,600
-71% -$10.3M ﹤0.01% 2567
2014
Q2 		$14.5M Sell
153,400
-29,800
-16% -$2.09M ﹤0.01% 1632
2014
Q1 		$13M Sell
183,200
-39,400
-18% -$3.12M ﹤0.01% 1581
2013
Q4 		$16.5M Buy
222,600
+217,500
+4,265% +$15.1M 0.01% 1452
2013
Q3 		$387K Sell
5,100
-2,000
-28% -$159K ﹤0.01% 4849
2013
Q2 		$568K Buy
+7,100
New +$523K ﹤0.01% 4626

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America's VRTX Position: Q1 2026 in Review

Bank of America reduced its Vertex Pharmaceuticals (VRTX) stake by 2% in Q1 2026, selling an estimated $27.4M and leaving 2,878,183 shares worth $1.29B. The position accounts for 0.09% of the portfolio, ranked #207.

Bank of America first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.39B in Q1 2025. 1,692 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Bank of America held 2,878,183 shares of Vertex Pharmaceuticals worth $1.29B as of Q1 2026.
  • Bank of America sold 58,847 Vertex Pharmaceuticals shares in Q1 2026, an estimated $27.4M.
  • Vertex Pharmaceuticals made up 0.09% of Bank of America's portfolio in Q1 2026, its #207 holding.
  • Bank of America first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Vertex Pharmaceuticals position peaked at $1.39B in Q1 2025.
  • 1,692 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.